Researchers seek better ways to predict Waldenstrom's outcomes
NCT ID NCT05911802
First seen Dec 29, 2025 · Last updated May 06, 2026 · Updated 20 times
Summary
This study aims to improve how doctors predict the course of Waldenstrom's macroglobulinemia, a rare blood cancer. Researchers will analyze data from 500 patients to validate existing prognostic indexes and evaluate whether progression-free survival can reliably predict overall survival. The goal is to help guide treatment decisions and design better clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMIENS - CH Amiens Picardie Site Sud
NOT_YET_RECRUITINGAmiens, 80054, France
Contact Email: •••••@•••••
-
APHP - Hôpital Pitié Salpêtrière - Hématologie
NOT_YET_RECRUITINGParis, 75651, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Angers Chu
NOT_YET_RECRUITINGAngers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clermont-Ferrand - Chu Estaing
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
Contact Email: •••••@•••••
-
Institut Bergonie
NOT_YET_RECRUITINGBordeaux, 33076, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Paoli Calmette
NOT_YET_RECRUITINGMarseille, 130009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LENS - GHT Artois
NOT_YET_RECRUITINGLens, 62300, France
Contact Email: •••••@•••••
-
LIBOURNE - Hôpital Robert Boulin
NOT_YET_RECRUITINGLibourne, 33505, France
Contact Email: •••••@•••••
-
LILLE GHICL - Hôpital Saint Vincent de Paul
RECRUITINGLille, 59000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Le Mans CH
NOT_YET_RECRUITINGLe Mans, France
Contact Email: •••••@•••••
-
POITIERS - Hématologie et Thérapie Cellulaire
NOT_YET_RECRUITINGPoitiers, 86021, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Reims Chu
NOT_YET_RECRUITINGReims, 51092, France
Contact Email: •••••@•••••
-
Strasbourg - Icans
NOT_YET_RECRUITINGStrasbourg, 67033, France
Contact Email: •••••@•••••
-
Toulouse - IUCT Oncopole - Service d'Hématologie
NOT_YET_RECRUITINGToulouse, 31059, France
Contact Email: •••••@•••••
-
VERSAILLES - Hôpital André Mignot
NOT_YET_RECRUITINGVersailles, France
Contact
Conditions
Explore the condition pages connected to this study.